SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-22-001694
Filing Date
2022-01-26
Accepted
2022-01-26 16:15:01
Documents
13

Document Format Files

Seq Description Document Type Size
1 FORM S-3 rvph20220124_s3.htm S-3 512356
2 EXHIBIT 1.2 ex_328251.htm EX-1.2 207323
3 EXHIBIT 4.5 ex_327633.htm EX-4.5 414498
4 EXHIBIT 4.6 ex_327634.htm EX-4.6 445855
5 EXHIBIT 5.1 ex_328252.htm EX-5.1 25902
6 EXHIBIT 23.1 ex_328253.htm EX-23.1 5643
7 footer.jpg GRAPHIC 6486
8 logosmall.jpg GRAPHIC 4070
9 lowenimg.jpg GRAPHIC 10231
10 rvph20220124_s3img001.jpg GRAPHIC 4149
11 rvph20220124_s3img002.jpg GRAPHIC 4149
12 rvph20220124_s3img003.jpg GRAPHIC 4149
13 rvph20220124_s3img004.jpg GRAPHIC 4149
  Complete submission text file 0001437749-22-001694.txt   1664865
Mailing Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-262348 | Film No.: 22558051
SIC: 2834 Pharmaceutical Preparations